These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7975501)

  • 1. Recent advances in the preparation and storage of red cells.
    Högman CF
    Vox Sang; 1994; 67 Suppl 3():243-6. PubMed ID: 7975501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of blood oxygen affinity in different CPD solutions during liquid storage.
    Wells RM; Hill RS; Woodfield DG
    Transfusion; 1981; 21(6):709-14. PubMed ID: 7314220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
    Högman CF; Eriksson L; Gong J; Högman AB; Vikholm K; Debrauwere J; Payrat JM; Stewart M
    Vox Sang; 1993; 65(4):271-8. PubMed ID: 8310679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutions.
    Högman CF; Eriksson L; Gong J; Payrat JM; Debrauwere J
    Transfus Med; 1993 Mar; 3(1):43-50. PubMed ID: 8038896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved red blood cell storage using optional additive systems (OAS) containing adenine, glucose and ascorbate-2-phosphate.
    Moore GL; Ledford ME; Brummell MR
    Transfusion; 1981; 21(6):723-31. PubMed ID: 7314223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and preservation of red cells.
    Högman CF
    Vox Sang; 1998; 74 Suppl 2():177-87. PubMed ID: 9704444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of rejuvenation on 2, 3-DPG level of preserved red blood cells.
    Kiartivich S; Talalak P; Chandanayingyoung D
    J Med Assoc Thai; 1986 Dec; 69(12):665-71. PubMed ID: 3572281
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of rejuvenation solutions in blood preservation.
    Valeri CR
    Crit Rev Clin Lab Sci; 1982; 17(4):299-374. PubMed ID: 6756785
    [No Abstract]   [Full Text] [Related]  

  • 10. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
    Moore GL; Ledford ME; Unruh KA; Brummell MR
    Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-separation storage of whole blood: the effect of temperature on red cell 2,3-diphosphoglycerate and myeloperoxidase in plasma.
    Knutson F; Lööf H; Högman CF
    Transfus Sci; 1999 Oct; 21(2):111-5. PubMed ID: 10747518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Storage of red blood cells with improved maintenance of 2,3-bisphosphoglycerate.
    Högman CF; Löf H; Meryman HT
    Transfusion; 2006 Sep; 46(9):1543-52. PubMed ID: 16965582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
    Wiltshire M; Cardigan R; Thomas S
    Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term storage and preservation of red blood cells.
    Moore GL
    Biotechnology; 1991; 19():31-46. PubMed ID: 1786474
    [No Abstract]   [Full Text] [Related]  

  • 15. Additive solution-7 reduces the red blood cell cold storage lesion.
    Cancelas JA; Dumont LJ; Maes LA; Rugg N; Herschel L; Whitley PH; Szczepiokowski ZM; Siegel AH; Hess JR; Zia M
    Transfusion; 2015 Mar; 55(3):491-8. PubMed ID: 25233911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of red cell storage lesion: a comparison of five different additive solutions.
    Lagerberg JW; Korsten H; Van Der Meer PF; De Korte D
    Blood Transfus; 2017 Sep; 15(5):456-462. PubMed ID: 28488968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell and platelet concentrates from blood collected into half-strength citrate anticoagulant: improved maintenance of red cell 2,3-diphosphoglycerate in half-citrate red cells.
    Farrugia A; Douglas S; James J; Whyte G
    Vox Sang; 1992; 63(1):31-8. PubMed ID: 1413661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and membrane functional alterations in red cells during preparation and storage of leukocyte- and platelet-poor red cell suspensions prepared by warm-centrifuge method.
    Shimizu T; Ishikawa Y; Furuta A; Fukuda T
    Tohoku J Exp Med; 1985 Mar; 145(3):321-8. PubMed ID: 4002219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsphere encapsulated l-ascorbic acid: its effects on erythrocytes during 56 days storage.
    Truter EJ
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1107-9. PubMed ID: 1391431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.